• 1. Artificial Organ Technology Laboratory, School of Mechanical and Electrical Engineering, Soochow University, Suzhou, Jiangsu 215131, P. R. China;
  • 2. Jiangsu Province Key Laboratory of Precision Medicine Equipment Design and Manufacturing, School of Mechanical Engineering, Southeast University, Nanjing 211189, P. R. China;
  • 3. Institute for Medical Devices Control, National Institutes for Food and Drug Control, Beijing 102629, P. R. China;
  • 4. Precision and Intelligence Medical Imaging Lab, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P. R. China;
ZHANG Liudi, Email: liudi@suda.edu.cn; WU Peng, Email: 101013707@seu.edu.cn
Export PDF Favorites Scan Get Citation

In vitro hemolysis testing for blood pumps currently faces several challenges, including randomness in control group selection, and numerous sources of uncertainty in the testing methods. These issues lead to high uncertainty, insufficient result credibility, and limited comparability, which hinders the effective evaluation of blood damage induced by blood pumps. This study aims to address these limitations by developing a magnetically-levitated blood pump benchmark model and optimizing the hemolysis testing protocol to reduce result uncertainty. A magnetic bearing was utilized to minimize blood damage, and the injection molding was employed to enhance the machining precision of the pump. The experimental procedures, including blood collection, test loop setup, and the testing process, were optimized to effectively control experimental uncertainty. The results showed that the performance curve of the benchmark pump model was flat, and the coefficient of variation for the hydraulic experimental results was less than 5%. The secondary flow path exhibited good blood washout with no thrombus formation. Under low-flow condition, the average normalized index of hemolysis (NIH) was 0.014 g/100L, with a coefficient of variation of 19.50%. Under high-flow condition, the average NIH was 0.045 g/100L, with a coefficient of variation of 16.45%. The hemolysis values under both conditions were lower than the Abbott CentriMag. In conclusion, we designed a benchmark blood pump model with excellent hemocompatibility and optimized hemolysis testing protocol, which led to low uncertainty in experimental results. The benchmark and optimized hemolysis protocol help to improve the credibility and comparability of in vitro hemolysis testing data, providing a reliable solution for both the industry and regulatory agencies to assess hemocompatibility.

Citation: WANG Xiaodong, DU Guanting, ZHANG Liudi, LI Shu, WU Peng. Design of a benchmark pump model and optimization of hemolysis testing protocol for evaluation of blood pump hemocompatibility. Journal of Biomedical Engineering, 2026, 43(1): 106-113. doi: 10.7507/1001-5515.202503047 Copy

Copyright ? the editorial department of Journal of Biomedical Engineering of West China Medical Publisher. All rights reserved

  • Previous Article

    A scientific definition of brain-computer interfaces (BCIs): Essential components, fundamental characteristics, capability boundaries, and scope delimitation
  • Next Article

    Numerical simulation study on the influence of free edge configuration on the performance of polymeric heart valves